Lipo-C
Lipotropic Complex / MIC Injection
Lipo-C (Lipotropic Compound) is an injectable formulation combining methionine, inositol, and choline (MIC) with B-complex vitamins (typically B1, B2, B5, B6, and B12), designed to support fat metabolism, liver function, and energy production. It is commonly prescribed by weight loss clinics and functional medicine practitioners as an adjunct to diet and exercise programs. While not a peptide in the strict biochemical sense, Lipo-C is frequently categorized alongside peptide therapies in clinical weight management protocols.
Wirkmechanismus
Lipotropic injection containing methionine, inositol, choline, and commonly supplemented with L-carnitine, B12, and B-complex vitamins. Enhances hepatic fat metabolism, supports methylation pathways, and promotes bile flow for improved lipid processing.
Forschungsprotokolle
Nur für Forschungszwecke. Keine medizinische Beratung.
Protocols typically use 1ml intramuscular injection weekly. Some protocols use twice weekly during active weight management. Often combined with dietary and exercise programs.
Forschungsnotizen
Clinical Research Status
Lipotropic injections have been used in clinical practice for decades, though high-quality randomized controlled trials specifically evaluating the MIC + B-vitamin combination for fat loss are limited. Individual components have established biochemical roles in fat metabolism: methionine as a lipotropic amino acid, inositol as a secondary messenger in insulin signaling, and choline as essential for VLDL assembly and hepatic fat export. The combination is prescribed under physician supervision at compounding pharmacies but is not FDA-approved as a specific weight loss drug.
Key Published Findings
Methionine serves as a methyl donor essential for phosphatidylcholine synthesis and fat mobilization from hepatocytes, with deficiency directly linked to hepatic steatosis in animal models. Inositol research demonstrates improved insulin sensitivity and reduced body weight in polycystic ovary syndrome (PCOS) patients at doses of 2-4g daily in multiple randomized trials. Choline deficiency is associated with fatty liver disease, and adequate choline status supports VLDL secretion necessary for hepatic fat clearance.
Safety Profile
MIC injections are generally well-tolerated, with the most common side effects being injection site soreness, mild gastrointestinal discomfort, and occasional headache. B-vitamin components are water-soluble with wide therapeutic margins, though B6 neurotoxicity is possible at very high chronic doses. Methionine supplementation should be used cautiously in individuals with elevated homocysteine levels unless adequate B6, B12, and folate are co-administered to support the methylation cycle.
Comparison to Related Compounds
Lipo-C differs from single-agent weight loss peptides like semaglutide or tirzepatide by targeting hepatic fat metabolism rather than appetite suppression or incretin signaling. Compared to L-carnitine injections which facilitate mitochondrial fatty acid transport, MIC components address earlier steps in fat mobilization and export from the liver. Injectable administration provides higher bioavailability than oral supplements, particularly for B12 in patients with absorption issues, though the clinical significance of this advantage for the other components is debated.
Community Observations
Users at weight loss clinics typically receive weekly or twice-weekly injections as part of comprehensive programs including caloric restriction and exercise. Many report increased energy levels within hours of injection, likely attributable to B-vitamin components rather than fat metabolism effects which would be more gradual. Results are generally described as supportive rather than dramatic, with most practitioners positioning Lipo-C as a metabolic optimization tool rather than a primary weight loss intervention.
Halbwertszeit
N/A (vitamin complex)
Rekonstitution
Pre-mixed solution (no reconstitution required)
Lagerung
Lyophilisiert
Refrigerate 2-8C. Protect from light.
Rekonstituierter
Refrigerate 2-8C. Stable for 90 days.
Rechtsstatus USA
Auch bekannt als
Häufig gestellte Fragen
Was ist Lipo-C?
Lipo-C (Lipotropic Compound) is an injectable formulation combining methionine, inositol, and choline (MIC) with B-complex vitamins (typically B1, B2, B5, B6, and B12), designed to support fat metabolism, liver function, and energy production. It is commonly prescribed by weight loss clinics and functional medicine practitioners as an adjunct to diet and exercise programs. While not a peptide in the strict biochemical sense, Lipo-C is frequently categorized alongside peptide therapies in clinical weight management protocols.
Wie wirkt Lipo-C?
Lipotropic injection containing methionine, inositol, choline, and commonly supplemented with L-carnitine, B12, and B-complex vitamins. Enhances hepatic fat metabolism, supports methylation pathways, and promotes bile flow for improved lipid processing.
Wie ist der regulatorische Status von Lipo-C in den USA?
Supplement/compounded medication
Wie lang ist die Halbwertszeit von Lipo-C?
N/A (vitamin complex)
Wie wird Lipo-C noch genannt?
Lipotropic Complex, MIC Injection
Peptide Contacts bietet wissenschaftliche Zusammenfassungen für informationstechnische Zwecke an. Wir stellen keine Dokumentationen von Anbietern, keine Host- und keine Vertriebsdienstleistungen zur Verfügung und unterstützen keine Anbieter in irgendeiner Weise. Alle Zertifikate der Analyse, GMP-Zertifikate und Kommunikationen mit Anbietern müssen direkt vom Käufer angefordert und überprüft werden. Alles auf dieser Plattform stellt weder rechtliche, medizinische noch berufsmäßige Beratung dar. Nutzer sind allein verantwortlich für die Überprüfung der Anbieterzertifikate und das Gewährleisten des Einhaltens aller anwendbaren lokalen, zuständigen und federalen Gesetze beim Kauf von Forschungschemikalien. Die Nutzung dieser Plattform bedeutet die Annahme volles persönlichen Verantwortlichkeitsbewusstseins.
Ganze Erklärung lesen